BioSpace News Archive

Business

American Heart Association Welcomes Senior Vice President of Health Strategies

American Heart Association (AHA), Midwest Affiliate, has named Dr. Jeff Willett as its new Senior Vice President of Health Strategies.

August 2, 2018
·
2 min read
Business

PulsePoint CEO Sloan Gaon Recognized in PharmaVOICE 100

Award Recognizes Influential Individuals Throughout The Life Sciences Industry

August 2, 2018
·
3 min read
Business

Agenus to Report Second Quarter 2018 Financial Results on August 9, 2018 and Host Conference Call and Webcast

Agenus Inc.. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune checkpoint antibodies, cancer vaccines, and adoptive cell therapies1, will release its second quarter 2018 financial results before the market opens on Thursday, August 9, 2018.

August 2, 2018
·
3 min read
Business

Conisus, a leading provider of hematology and oncology brand strategy, business intelligence, and educational programming

In the first half of 2018, Conisus, a strategic marketing and medical communications agency focused on brand strategy, business intelligence (BI), and peer-to-peer programming, announced several important accomplishments.

August 2, 2018
·
4 min read
FDA

Hologic Announces FDA Clearance of the Panther Fusion® GBS Assay

System’s Latest Assay Increases Lab Efficiency and Flexibility With Highly Sensitive and Specific Detection

August 2, 2018
·
4 min read
Business

Sensus Healthcare 2018 Second Quarter Financial Results Feature Continued Strong Revenue Growth

Ships 21 systems including 12 SRT-100 Vision™ systems

August 2, 2018
·
22 min read
Policy

IONIS-HTT Rx (RG6042) Granted PRIME Designation by the European Medicines Agency for the Treatment of People with Huntington’s Disease

IONIS-HTT Rx is the first and only drug to demonstrate reduction of mutant huntingtin protein, the underlying cause of Huntington’s disease, in patients

August 2, 2018
·
6 min read
Business

Aratana Therapeutics Reports Second Quarter 2018 Financial Results

Aratana Therapeutics, Inc. announced its second quarter 2018 financial results.

August 2, 2018
·
20 min read
Business

Bruker Reports Second Quarter 2018 Financial Results

Bruker Corporation announced financial results for its second quarter and six months ended June 30, 2018.

August 2, 2018
·
55 min read
Deals

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) on July 31, 2018

Akebia Therapeutics, Inc. granted eight newly-hired employees options to purchase an aggregate of 37,400 shares of Akebia’s common stock on July 31, 2018, as inducements material to each such employee’s entering into employment with Akebia.

August 2, 2018
·
1 min read